Treatment of Lassa fever is very simple. It involves the administration of the antiviral drug ribavirin1,2 while supportive care is given to keep the patient comfortable, and that is it. The treatment is very affective, too. Normally, Lassa fever has a mortality rate of 20-58%3, but with ribavirin treatment, the mortality rate drops to 5%2. Not only could diagnosing Lassa fever earlier save lives by preventing dangerous surgeries, but it could also save a lot of time in money in other ways by starting this simple and effective treatment.
There are some problems with diagnosing Lassa fever pre-surgery, though. As described earlier, the symptoms of Lassa fever are very similar to those of other diseases, so diagnostic mistakes may be made. Also, there are no known methods for testing for the presence of Lassa fever in the early onset of the disease, as the symptoms are nonspecific before the mucosal bleeding begins.4,5 Lastly, even when Lassa fever is expected, diagnostic facilities in Western Africa typically lack the equipment necessary to test for its presence.5 To solve these problems, a sort of checklist needed to be made to help with the diagnosis of Lassa fever.
Dongo et al. did a case study on seven different patients diagnosed with Lassa fever after going through abdominal surgery. They hoped to find certain symptoms that were common among all of the cases, but were also unique to Lassa fever. The researchers ended up finding many common symptoms throughout the cases, all of which are outlined in Table 1. Every patient had a fever among admission to the treatment center. Four out of the seven of them had very low white blood cell counts, and two had very low platelet counts, or thrombocytopenia. Another four of them had prolonged bleeding times when cut or pricked. A few of the patients also exhibited ascites, which is the build up of fluid in the abdomen. Because of the hemorrhagic nature of Lassa fever, the built up fluid consists mainly of blood. This blood also gets excreted through the urinary tract, causing the patient’s urine to be bloody in a symptom known as hematuria. Lastly, proteinuria was common in some of the cases, which is the presence of excess protein in a patient’s urine.
While all of these symptoms are good indicators of Lassa fever, they are not all exclusive to the disease. Dongo et al. have limited the list of symptoms down to thrombocytopenia, high fever, proteinuria, and hematuria. Specifically, if a patient presents with thrombocytopenia as well as any of the other three symptoms, then there is a good chance they have Lassa fever, and they should be placed on ribavirin immediately. One last notable indicator the researchers included was the prolonged bleeding from any cut or prick. If the prolonged bleeding exists along with the other symptoms, the patient is even more likely to have Lassa fever.
Beyond that, this extensive bleeding is associated with a higher rate of transmission of the disease. In many of the case studies, the surgeons or other medical staff attending to the patients contracted Lassa fever.6,7 In the instances where this secondary infection occurred, every patient exhibited the prolonged bleeding, and in the instances where there was no prolonged bleeding, no transmission occurred.
Lassa fever is a highly lethal sickness endemic in
Western Africa that does
not get the attention that it needs. New
guidelines need to be implemented to help diagnose this disease when it is
present. When thrombocytopenia is
present along with hematuria, proteinuria, high fever, or prolonged bleeding,
it should be assumed that the patient has Lassa fever and the appropriate
precautions should be taken. Doing so
will prevent potentially life threatening surgeries, save time and money, and
halt the transmission of the disease to healthcare workers.
Dongo AE, Kesieme EB, Iyamu CE, Okokhere PO, Akhuemokhan OC, Akpede GO: Lassa fever presenting as acute abdomen: a case series. Virology Journal 2013, 10:123.
1. Richmond JK, Baglole DJ: Lassa fever: epidemiology, clinical features, and social
consequences. BMJ 2003, 327:1271-1275.
2. Mccormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliot LH,
Belmont-William R: Lassa fever: Effective therapy with Ribavirin. N Engl J Med 1986, 314:20-26.
3. Khan SH, Goba A, Chu M: New opportunities for research on the pathogenesis and treatment of Lassa fever. J Antiviral 2008, 78:103-115.
4. CDC Lassa fever fact sheet. CDC infectious disease information. Viral haemorrhagic fever. http://www.cdc.gov/ncidod/dvrd/spb/mnpage/dispages/Lassaf.htm
5. Bausch DG: Viral haemorrhagic fevers. In Clinical Infectious disease. Edited by Schlossberg D.
6. Bowen GS, Tomori O, Wulff H, Cassals J, Noonan F, Downs WG: Lassa fever in Onitsha,
Nigeria in 1974.Bull World Health Organ 1975, 52:599-604.
7. Fischer-Hoch SP, Tomori O, Nasidi A: Review of cases of nosocomial Lassa fever In Nigeria: The high price of poor medical practice. BMJ 1995, 311:857-859.